Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation
A Randomized Controlled Trial
- George Doukas, FRCSI;
- Nilesh J. Samani, MD, FRCP;
- Christos Alexiou, FRCS, PhD;
- Mehmet Oc, MD;
- Derek T. Chin, MD;
- Peter G. Stafford, MD;
- Leong L. Ng, MD;
- Tomasz J. Spyt, FRCS, MD
- Author Affiliations: Departments of Cardiac Surgery (Drs Doukas, Alexiou, Oc, and Spyt) and Cardiology (Drs Samani, Chin, and Stafford), Glenfield Hospital, University Hospitals of Leicester NHS Trust, and the Department of Cardiovascular Sciences, University of Leicester(Drs Doukas, Samani, Ng, and Spyt), Leicester, England.
- Correspondence: George Doukas, FRCSI, Department of Cardiac Surgery, Glenfield Hospital, Groby Road, Leicester LE3 9QP, England (doukas_george{at}hotmail.com).
Abstract
Context Although left atrial radiofrequency ablation (RFA) is increasingly used for the treatment of chronic atrial fibrillation during mitral valve surgery, its efficacy to restore sinus rhythm and any resulting benefits have not been examined in the context of an adequately powered randomized trial.
Objective To determine whether intraoperative RFA of the left atrium increases the long-term restoration of sinus rhythm and improves exercise capacity.
Design, Setting, and Patients Randomized, double-blind trial performed in a single UK tertiary referral center with enrollment between December 2001 and November 2003. A total of 101 patients referred for mitral valve surgery with at least 6 months’ history of uninterrupted atrial fibrillation were assessed for eligibility; 97 were enrolled. Patients were followed up for 12 months.
Intervention Patients were randomly assigned to undergo mitral valve surgery and RFA of the left atrium (n = 49) or mitral valve surgery alone (controls; n = 48).
Main Outcome Measures The primary outcome measure was presence of sinus rhythm at 12 months; secondary measures were patient functional status and exercise capacity (assessed by shuttle-walk test), left atrial contractility, and left atrial and left ventricular dimension and function and plasma levels of B-type natriuretic peptide.
Results At 12 months, sinus rhythm was present in 20 (44.4%) of 45 RFA patients and in 2 (4.5%) of 44 controls (rate ratio, 9.8; 95% CI, 2.4-86.3; P<.001). Restoration of sinus rhythm in the RFA group was accompanied by a greater improvement in mean (SD) shuttle-walk distance compared with controls (+94 [102] m vs +48 [82] m; P = .003) and a greater reduction in the plasma level of B-type natriuretic peptide (−104 [87] fmol/mL vs −51 [82] fmol/mL; P = .03). Patients randomized to receive RFA had similar rates of postoperative complications and deaths as control patients.
Conclusions Radiofrequency ablation of the left atrium during mitral valve surgery for continuous atrial fibrillation significantly increases the rate of sinus rhythm restoration 1 year postoperatively, improving patient exercise capacity. On the basis of its efficacy and safety, routine use of RFA of the left atrium during mitral valve surgery may be justified.
Trial Registration ClinicalTrials.gov Identifier: NCT00238706.
